This may be because that disease activity in pregnant RA women was usually controlled using glucocorticoids, which may decrease the sensitivity of peripheral insulin, increase the production of hepatic glucose, and inhibit the production and secretion of pancreatic insulin [52], thereby promoting the development of diabetes in patients with RA [53, 54]. Here, INS is linked to diabetes mellitus.